Skip to main navigation
Skip to search
Skip to main content
Experts@Minnesota Home
Home
Profiles
Research units
University Assets
Projects and Grants
Research output
Press/Media
Datasets
Activities
Fellowships, Honors, and Prizes
Search by expertise, name or affiliation
A randomized, controlled trial of Ebola virus disease therapeutics
PALM Writing Group
Biostatistics
Research output
:
Contribution to journal
›
Article
›
peer-review
1039
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'A randomized, controlled trial of Ebola virus disease therapeutics'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine and Dentistry
Combination Therapy
100%
Virus Infection
100%
Ebolavirus
100%
Patient
100%
Randomized Controlled Trial
100%
ZMapp
100%
Monoclonal Antibody
42%
Death
28%
Mortality
28%
Remdesivir
28%
Monitoring
14%
Assay
14%
Symptom
14%
Clinical Research
14%
Intravenous Drug Administration
14%
Age
14%
Survival
14%
Antivirus Agent
14%
Serum
14%
Epidemic
14%
Adverse Event
14%
Virus RNA
14%
Creatinine
14%
Experimental Therapy
14%
Drug Screening
14%
Interim Analysis
14%
Experimental Therapeutic
14%
Transaminase
14%
Immunology and Microbiology
Ebola Virus
100%
ZMapp
100%
Monoclonal Antibodies
42%
Mortality
28%
Time
28%
Age
14%
Survival
14%
RNA Virus
14%
Sound
14%
Viral Load
14%
Creatinine Blood Level
14%
Drug Screening
14%
Aminotransferase Blood Level
14%
Pharmacology, Toxicology and Pharmaceutical Science
Ebola Virus Disease
100%
Monoclonal Antibody
42%
Death
28%
Mortality
28%
Remdesivir
28%
Symptom
14%
Survival
14%
Antivirus Agent
14%
Ebola Hemorrhagic Fever
14%
Adverse Event
14%
Drug Screening
14%
Creatinine
14%
Aminotransferase
14%
Epidemic
14%
Virus RNA
14%